Tn125-Related Acquisition ofblaNDM-Like Genes in Acinetobacter baumannii
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tn125-Related Acquisition ofblaNDM-Like Genes in Acinetobacter baumannii
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 56, Issue 2, Pages 1087-1089
Publisher
American Society for Microbiology
Online
2011-12-06
DOI
10.1128/aac.05620-11
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- International Transfer of NDM-1-ProducingKlebsiella pneumoniaefrom Iraq to France
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Features ofblaNDM-1-Positive Enterobacteriaceae
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of the Resistome of a Multidrug-Resistant NDM-1-Producing Escherichia coli Strain by High-Throughput Genome Sequencing
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Updated multiplex polymerase chain reaction for detection of 16S rRNA methylases: high prevalence among NDM-1 producers
- (2011) Béatrice Berçot et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Multiplex PCR for detection of acquired carbapenemase genes
- (2011) Laurent Poirel et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007
- (2011) Yvonne Pfeifer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland
- (2011) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Does broad-spectrum -lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
- (2011) P. Nordmann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- NDM-2 carbapenemase in Acinetobacter baumannii from Egypt
- (2011) M. Kaase et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Balkan NDM-1: escape or transplant?
- (2011) David M Livermore et al. LANCET INFECTIOUS DISEASES
- Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme
- (2010) A. Di Popolo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India
- (2010) K. Karthikeyan et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global spread of New Delhi metallo-β-lactamase 1
- (2010) Stephan Göttig et al. LANCET INFECTIOUS DISEASES
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
- (2010) Karthikeyan K Kumarasamy et al. LANCET INFECTIOUS DISEASES
- The Population Structure of Acinetobacter baumannii: Expanding Multiresistant Clones from an Ancestral Susceptible Genetic Pool
- (2010) Laure Diancourt et al. PLoS One
- blaCMY-2-Positive IncA/C Plasmids from Escherichia coli and Salmonella enterica Are a Distinct Component of a Larger Lineage of Plasmids
- (2009) D. R. Call et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- VIM-19, a Metallo- -Lactamase with Increased Carbapenemase Activity from Escherichia coli and Klebsiella pneumoniae
- (2009) J.-M. Rodriguez-Martinez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Whole-Genome Pyrosequencing of an Epidemic Multidrug-Resistant Acinetobacter baumannii Strain Belonging to the European Clone II Group
- (2008) M. Iacono et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evolution of the ISCR3 Group of ISCR Elements
- (2008) M. A. Toleman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Structure Associated with blaOXA-18, Encoding a Clavulanic Acid-Inhibited Extended-Spectrum Oxacillinase
- (2008) T. Naas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started